Skip to main content
FinSpry Logo
FinSpry
KYMR logo
KYMR
(NASDAQ)
Kymera Therapeutics, Inc.
$85.40-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kymera Therapeutics (KYMR) Stock Price & Financial Analysis

Kymera Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$82.67 - $85.65
52-Week High$103.00
52-Week Low$19.45
Open$82.78
Volume690.89K
Average Volume (3M)690.89K
Market Cap7.21B
Shares Outstanding84.39M
Price to Sales (P/S)182.84
Price to Book (P/B)4.54
EV/EBITDA-22.75
Revenue (TTM)39.20M
Net Income (TTM)-311.40M
Free Cash Flow (TTM)-234.34M
EPS (TTM)$-3.69
Profit Margin-794.39%
Operating Margin-881.49%
Return on Equity (ROE)-19.71%
Debt to Equity0.05
50-Day MA$80.78
200-Day MA$62.91
52-Week Change236.56%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Kymera Therapeutics

What is the current stock price for KYMR?

As of the latest trading session, KYMR stock trades at $85.40. The 52-week range is $19.45–$103.00, with a day range of $82.67–$85.65.

What is the P/E ratio for KYMR?

The P/E ratio (Price-to-Earnings) for KYMR is shown in the Key Statistics section. This valuation metric helps compare Kymera Therapeutics, Inc. to industry peers.

Does KYMR pay dividends?

Kymera Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KYMR?

Based on 8 analysts, the consensus for KYMR is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KYMR?

Kymera Therapeutics's market capitalization is $7.21B, classifying it as a mid-cap company. Kymera Therapeutics operates in the Healthcare sector within the Biotechnology industry.